Medical treatment of epilepsy: Part II.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000328:Adult; D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002118:Calcium / Q000097:blood; D002648:Child; D004347:Drug Interactions; D004827:Epilepsy / Q000097:blood / Q000188:drug therapy*; D004830:Epilepsy, Tonic-Clonic / Q000188:drug therapy; D005260:Female; D005885:Gingival Hyperplasia / Q000139:chemically induced; D006801:Humans; D006948:Hyperkinesis / Q000139:chemically induced; D010634:Phenobarbital / Q000097:blood; D010672:Phenytoin / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood; D011247:Pregnancy; D011324:Primidone / Q000097:blood; D013226:Status Epilepticus / Q000188:drug therapy
D000927:Anticonvulsants; D011324:Primidone; D010672:Phenytoin; D002118:Calcium; D010634:Phenobarbital